课题基金 / 基金详情

ORAL AND IV NAVELBINE (VINORELBINE) IN PEDIATRIC CANCER PATIENTS

ORAL AND IV NAVELBINE (VINORELBINE) IN PEDIATRIC CANCER PATIENTS
小儿癌症患者口服和静脉注射长春瑞滨（长春瑞滨）
批准号：
6244586
负责人：
RAYMOND J HUTCHINSON
金额：
$2.22万
依托单位：
UNIVERSITY OF MICHIGAN AT ANN ARBOR
依托单位国家：
美国
项目类别：
财政年份：
1997
资助国家：
美国
项目状态：
已结题
起止时间：
1997-02-20 至 1997-11-30
来源：
https://reporter.nih.gov/project-details/6244586
关键词：
antineoplastics child (0-11) clinical research clinical trial phase I drug screening /evaluation human subject human therapy evaluation intravenous administration neoplasm /cancer chemotherapy oral administration pediatric neoplasm /cancer pediatric pharmacology vinca alkaloids

项目摘要

项目成果

RAYMOND J HUTCHINSON的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
CCG-0936 is a phase 1 pediatric trial of Navelbine, a unique semi- synthetic vinca alkaloid which differs from other vincas in that the catharanthine ring rather than the vindoline ring structure is modified. This structural change imparts pharmacologic properties which may translate into clincal benefits in the treatment of human cancers.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Effect of recipient age /graft vs host disease post BMT
VACCINE THERAPY OF PEDIATRIC MALIGNANCIES UTILIZING DENDRITIC CELLS
VACCINE THERAPY OF PEDIATRIC MALIGNANCIES UTILIZING DENDRITIC CELLS
CONTINUOUS 21 DAY INFUSION OF TOPOTECAN IN CHILDREN WITH RELAPSED SOLID TUMORS